Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
BackgroundAmong women, breast cancer is the leading cause of cancer-related death worldwide. Estrogen receptor α-positive (ERα+) breast cancer accounts for 70% of all breast cancer subtypes. Although ERα+ breast cancer initially responds to estrogen deprivation or blockade, the emergence of resistan...
Main Authors: | Jharna Datta, Natalie Willingham, Jasmine M. Manouchehri, Patrick Schnell, Mirisha Sheth, Joel J. David, Mahmoud Kassem, Tyler A. Wilson, Hanna S. Radomska, Christopher C. Coss, Chad E. Bennett, Ramesh K. Ganju, Sagar D. Sardesai, Maryam Lustberg, Bhuvaneswari Ramaswamy, Daniel G. Stover, Mathew A. Cherian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.857590/full |
Similar Items
-
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
by: Rahul Mal, et al.
Published: (2020-10-01) -
Estrogen Receptor Signaling in Breast Cancer
by: Paulina Miziak, et al.
Published: (2023-09-01) -
Peering into the Brain’s Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders
by: Shokouh Arjmand, et al.
Published: (2023-09-01) -
The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer
by: Zhongqin Gong, et al.
Published: (2022-06-01) -
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
by: Rainer Girgert, et al.
Published: (2019-01-01)